Experimental design in HPLC separation of pharmaceuticals

Abstract

Design of Experiments (DoE) is an indispensable tool in contemporary drug analysis as it simultaneously balances a number of chromatographic parameters to ensure optimal separation in High Pressure Liquid Chromatography (HPLC). This manuscript briefly outlines the theoretical background of the DOE and provides step-by-step instruction for its implementation in HPLC pharmaceutical practice. It particularly discusses the classification of various design types and their possibilities to rationalize the different stages of HPLC method development workflow, such as the selection of the most influential factors, factors optimization and assessment of the method robustness. Additionally, the application of the DOE-based Analytical Quality by Design (AQbD) concept in the LC method development has been summarized. Recent achievements in the use of DOE in the development of stability-indicating LC and hyphenated LC-MS methods have also been briefly reported. Performing of Quantitative structure retention relationship (QSRR) study enhanced with DOE-based data collection was recomended as a future perspective in description of retention in HPLC system.

Quercetin Bioavailability Evaluation on Standardized Herbal Medicine Containing Guava Leaf Extract with HPLC

“…flow rates that are too fast and too slow can result in imperfect separation. The flow rate reviewed in this study was 1 mL/min (Moldoveanu & David, 2022;Petrásková et al, 2020;Stojanović et al, 2021).…”

Leveraging the power of supercritical fluid chromatography for eco-conscious solutions in pharmaceutical analysis

“…However, both NP-LC and HILIC modes have limitations, exhibiting inferior resolution, repeatability, and selectivity compared to RP-LC. In addition, there are serious sustainability issues associated with these techniques (2). With regard to the latter, LC practitioners are eagerly seeking strategies to reduce the environmental burden by exploring greener solvent alternatives and optimizing separation conditions to minimize the consumption of toxic solvents.…”

From lab to industrial development of lipid nanocarriers using quality by design approach

“…It is a virtually rotating design based on incomplete factorial design. The BBD requires 2 k (k-1) + Cp experimental runs ( Stojanović et al, 2021 ). Compared with CDD, BDD requires fewer experiments.…”